Renal Cancer News and Research

RSS
Researchers discover new approach to treat two lethal metastatic cancers

Researchers discover new approach to treat two lethal metastatic cancers

Paper highlights clinical and immunological activity of immatics’ IMA901 in renal cell carcinoma

Paper highlights clinical and immunological activity of immatics’ IMA901 in renal cell carcinoma

Combination treatment effective against melanoma

Combination treatment effective against melanoma

Elevated blood lead levels put smokers at higher risk for renal cell carcinoma

Elevated blood lead levels put smokers at higher risk for renal cell carcinoma

Immunicum receives Swedish approval to commence first clinical trial of patented cancer vaccine

Immunicum receives Swedish approval to commence first clinical trial of patented cancer vaccine

Early diagnosis of large intestine cancer could be feasible in the long term

Early diagnosis of large intestine cancer could be feasible in the long term

First computerized genome-scale model of cancer cell metabolism

First computerized genome-scale model of cancer cell metabolism

Alnylam second quarter revenue decreases to $20.6 million

Alnylam second quarter revenue decreases to $20.6 million

Onconova to initiate ESTYBON Phase II/III study in pancreatic cancer

Onconova to initiate ESTYBON Phase II/III study in pancreatic cancer

PGT, Quintiles collaborate to bring genomic testing into mainstream drug development

PGT, Quintiles collaborate to bring genomic testing into mainstream drug development

Jennerex, Transgene present JX-594 Phase 1 and 2 study data in liver cancer at EASL meeting

Jennerex, Transgene present JX-594 Phase 1 and 2 study data in liver cancer at EASL meeting

CytRx commences INNO-206 Phase 1b trial in advanced solid tumors

CytRx commences INNO-206 Phase 1b trial in advanced solid tumors

Oxford Biomedica’s TroVax(R) TRIST Phase III study results to be published in Cancer Immunology, Immunotherapy

Oxford Biomedica’s TroVax(R) TRIST Phase III study results to be published in Cancer Immunology, Immunotherapy

Synta fourth-quarter total collaboration revenue decreases to $3.0 million

Synta fourth-quarter total collaboration revenue decreases to $3.0 million

Positive clinical data of AVEO's tivozanib featured at 2011 ASCO Genitourinary Cancers Symposium

Positive clinical data of AVEO's tivozanib featured at 2011 ASCO Genitourinary Cancers Symposium

Researchers identify PBRM1 gene mutation in one in three patients with common form of renal cancer

Researchers identify PBRM1 gene mutation in one in three patients with common form of renal cancer

New genetic alteration predisposes individuals to Cowden syndrome

New genetic alteration predisposes individuals to Cowden syndrome

Charité begins implementation of MGN1601 clinical phase I/II study in renal cancer

Charité begins implementation of MGN1601 clinical phase I/II study in renal cancer

Xgeva receives FDA approval for prevention of SREs in patients with bone metastases

Xgeva receives FDA approval for prevention of SREs in patients with bone metastases

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer

Exelixis reports interim data of XL184 for metastatic castration-resistant prostate cancer